// App-Quantinova.ai

: CAPTAIN: Improvements in airflow obstruction in patients with uncontrolled asthma

Researchers

Presenter

  • Dave Singh

Principal Investigators

  • Zelie Bailes

  • Neil Barnes

  • Louis-Philippe Boulet

  • Roland Buhl

  • Rekha Chaudhuri

  • Frances Gardiner

  • Ian Pavord

  • Emilio Pizzichini

  • David Slade

  • Claus F. Vogelmeier

  • John Oppenheimer

Medical Centers

  • Johannes-Gutenberg Universitat Mainz, Mainz, Germany

  • University of Oxford, Oxford, United Kingdom

  • NIH/NIEHS, Research Triangle Park, United States of America

  • GSK, Brentford, Middlesex, United Kingdom,

  • Gartnavel General Hospital, Glasgow, United Kingdom

  • Rutgers New Jersey Medical School, Newark, NJ, United States of America

  • GSK & William Harvey Institute, Barts and The London School of Medicine and Dentistry, Brentford, Middlesex & London, United Kingdom

  • University of Manchester, Manchester, United Kingdom

  • Philipps-Universität Marburg, German Center for Lung Research (DZL), Marburg, Germany

  • GSK & Federal University of Santa Catarina, Brentford, Middlesex & Santa Catarina, United Kingdom

  • Laval University, Quebec, Quebec, Canada.

Locations

  • United States

  • Germany

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Advair HFA

  • Umeclidinium

Outcome

  • N/A


Study Design

  • Randomized

  • Double Blind/Blinded

  • Parallel Group

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A